Hyperlipidemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:


{{CMG}}
{{CMG}}
==[[Hyperlipidemiaoverview|Overview]]==
==[[Hyperlipidemiahistorical perspective|Historical Perspective]]==


==[[Hyperlipidemiaclassification|Classification]]==
[[Hyperlipidemiaclassification#Primary cardiac tumors|Primary cardiac tumors]] | [[Hyperlipidemiaclassification#Secondary cardiac tumors|Secondary cardiac tumors]]
==[[Hyperlipidemiapathophysiology|Pathophysiology]]==
[[Hyperlipidemiapathological findings|Pathological Findings]]
==[[Hyperlipidemiacauses|Causes]]==
==[[Hyperlipidemiadifferential diagnosis|Differentiating Hyperlipidemiafrom other Diseases]]==
==[[Hyperlipidemiaepidemiology and demographics|Epidemiology and Demographics]]==
==[[Hyperlipidemiarisk factors|Risk factors]]==
=====[[Hyperlipidemiarisk factors for embolization|Risk Factors for Embolization]]=====
==[[Hyperlipidemiascreening|Screening]]==
==[[Hyperlipidemianatural history|Natural History, Complications and Prognosis]]==
==Diagnosis==
[[Hyperlipidemiahistory and symptoms|History and Symptoms]] | [[Hyperlipidemiaphysical examination|Physical Examination]] | [[Hyperlipidemiastaging|Staging]] | [[Hyperlipidemialaboratory tests|Laboratory Findings]] | [[Hyperlipidemiaelectrocardiogram|Electrocardiogram]] | [[Hyperlipidemiachest x ray|Chest X Ray]] | [[HyperlipidemiaCT|CT]] | [[HyperlipidemiaMRI|MRI]] | [[Hyperlipidemiaechocardiography or ultrasound|Echocardiography]] | [[Hyperlipidemiaother imaging findings|Other Imaging Findings]] | [[Hyperlipidemiaother diagnostic studies|Other Diagnostic Studies]]
==Treatment==
[[Hyperlipidemiamedical therapy|Medical Therapy]] | [[Hyperlipidemiasurgery|Surgery]] | [[Hyperlipidemiaprimary prevention|Primary Prevention]] | [[Hyperlipidemiasecondary prevention|Secondary Prevention]]
==Case Studies==
:[[Hyperlipidemiacase study one|Case #1]]
----
==[[Hyperlipidemia overview | Overview]]==
==[[Hyperlipidemia overview | Overview]]==



Revision as of 14:42, 24 August 2012

For patient information click here Template:DiseaseDisorder infobox

Lipoprotein Disorders Microchapters

Patient Information

Overview

Causes

Classification

Hyperlipoproteinemia
Hypolipoproteinemia

Treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Primary cardiac tumors | Secondary cardiac tumors

Pathophysiology

Pathological Findings

Causes

Differentiating Hyperlipidemiafrom other Diseases

Epidemiology and Demographics

Risk factors

Risk Factors for Embolization

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Staging | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention

Case Studies

Case #1

Overview

Risk factors

Screening

Screening tests | Screening frequency

Causes

Classification

Treatment

NCEP recommendations for children and adolescents with high-risk hyperlipidemia

Recommendations for drug therapy | Statins | Adjuvant therapies

Pharmacotherapy

Statins | Niacin | Fibrate | Omega-3 fatty acids

Trial supportive data

Niacin

AIM HIGH study

References

External links

Hyperlipoproteinemia OMIM GPnotebook WebMD Others
Type I Online Mendelian Inheritance in Man (OMIM) 238600 Template:GPnotebook . MeritCare
Type IIa Online Mendelian Inheritance in Man (OMIM) 144400 Template:GPnotebook . Merck
Type IIb Template:GPnotebook .
Type III . Template:GPnotebook WebMD Yahoo
Type IV Online Mendelian Inheritance in Man (OMIM) 144600 Template:GPnotebook WebMD Yahoo
Type V Online Mendelian Inheritance in Man (OMIM) 144600 Template:GPnotebook . .

de:Hyperlipoproteinämie he:היפרליפידמיה sv:Hyperlipidemi


Template:WikiDoc Sources